The Correlation between Traditional Ultrasound Features and the Expression of Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor-2, and Ki-67 in Breast Carcinoma

The Correlation between Traditional Ultrasound Features and the Expression of Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor-2, and Ki-67 in Breast Carcinoma

Objective: To evaluate the correlation between traditional ultrasound and the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (Her-2), and Ki-67 expression in breast carcinoma.Methods: A retrospective analysis of 400 cases of breast cancer,...

Full description

Bibliographic Details
Main Author:	Ping Wang, MM, Junfan Li, Wensheng Yue, MM, Wenyan Li, MM, Yuqun Luo, MM
Format:	Article
Language:	English
Published:	Editorial Office of Advanced Ultrasound in Diagnosis and Therapy 2018-12-01
Series:	Advanced Ultrasound in Diagnosis and Therapy
Subjects:	\|traditional ultrasound\|breast cancer\|er\|pr\|her-2\|ki-67
Online Access:	http://www.journaladvancedultrasound.com:81/fileup/2576-2516/PDF/20180203002.pdf

Similar Items

The relationship of hormonal receptor, HER-2, and KI-67 changes after administration of anthracycline-based neoadjuvant chemotherapy with the results of histopathological grading in stage III breast cancer patients at Saiful Anwar Malang Regional Public H
by: Risal Wintoko, et al.
Published: (2019-12-01)

In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study
by: Anna L. V. Johansson, et al.
Published: (2021-02-01)

The expression of immunohistochemical markers estrogen receptor, progesterone receptor, Her-2-neu, p53 and Ki-67 in epithelial ovarian tumors and its correlation with clinicopathologic variables
by: Mary T Sylvia, et al.
Published: (2012-01-01)

Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters
by: Atif Ali Hashmi, et al.
Published: (2019-09-01)

Lokal ileri evre meme kanserli hastalarda neoadjuvan kemoterapinin ER, PR, c-erb2, VEGF ve Ki-67 üzerine etkisi
by: Ahmet Gökhan SARITAŞ, et al.
Published: (2019-03-01)

Associations of Estrogen Receptor, Progesterone Receptor, Human Epidemic Growth Factor Receptor-2 and Ki-67 with Ultrasound Signs and Prognosis of Breast Cancer Patients
by: Zhao X, et al.
Published: (2021-06-01)

Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma
by: Nornazirah Azizan, et al.
Published: (2018-07-01)

HUBUNGAN ANTARA STATUS RESEPTOR ESTROGEN, RESEPTOR PROGESTERON DAN HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 DENGAN DERAJAT KEGANASAN KARSINOMA PAYUDARA INVASIF
by: Muhartono Muhartono, et al.
Published: (2016-08-01)

Evaluation of estrogen and progesterone receptors and Her-2 expression with grading in the fine-needle aspirates of patients with breast carcinoma
by: Pampa Ch Toi, et al.
Published: (2018-01-01)

A Mathematical Model to Predict Diagnostic Periods for Secondary Distant Metastases in Patients with ER/PR/HER2/Ki-67 Subtypes of Breast Cancer
by: Ella Ya. Tyuryumina, et al.
Published: (2020-08-01)

Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy
by: Mark Laible, et al.
Published: (2019-07-01)

Folate receptor and Ki-67 nucleoprotein expressions in cervical cancer tissue and their correlation
by: Ran Yan, et al.
Published: (2016-01-01)

Expressions of Bcl-2, Bax and Ki67 in the primary pterygium
by: Juan Li, et al.
Published: (2018-05-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
by: Nasrin Shayanfar, et al.
Published: (2010-06-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
by: Nasrin Shayanfar, et al.
Published: (2010-05-01)

Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index
by: Sasagu Kurozumi, et al.
Published: (2017-05-01)

Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinoma
by: Ayesha Ahmed, et al.
Published: (2018-01-01)

Hubungan Ekspresi Ki-67 dengan Grading Histopatologi Liposarkoma
by: Afiati, et al.
Published: (2013-09-01)

Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01)

Immunoexpression of estrogen receptor-β and progesterone receptor in prostate adenocarcinoma, does it inhibit neoplastic proliferation and invasion?
by: Kinjal N Bera, et al.
Published: (2020-01-01)

Role of Ki-67 in the Grading of Mucoepidermoid Carcinomas
by: Sobia Siddique
Published: (2015-06-01)

Immunohistochemical Expression of Estrogen and Progesterone Receptors in Human colorectal Carcinoma (Clinicopathological study)
by: Sazan A. Mirza Al-Atrooshi
Published: (2014-10-01)

The Role of Endoscopic Ultrasound-Guided Ki67 in the Management of Non-Functioning Pancreatic Neuroendocrine Tumors
by: YongYan Cui, et al.
Published: (2020-03-01)

Immunoexpression of Ki-67 and endoglin corroborating hamartomatous nature of sialoangiolipoma
by: Swagatika Panda, et al.
Published: (2017-01-01)

A cytohistological study of Ki-67 expression in ovarian tumors
by: Monisha Choudhury, et al.
Published: (2011-01-01)

Comparison of immunohistochemical characteristics of expression estrogen receptors-alpha, progesterone receptors, p16, p53, Ki-67 and caspase 3 in invasive endometrial adenocarcinoma of different grade.
by: V. A. Tumanskiy, et al.
Published: (2016-09-01)

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience
by: Michela Palleschi, et al.
Published: (2020-08-01)

The cell proliferation antigen Ki-67 organises heterochromatin
by: Michal Sobecki, et al.
Published: (2016-03-01)

Clinicopathologic study and Ki-67 proliferative marker evaluation in human osteosarcomas Estudo clinicopatológico com avaliação do índice de proliferação celular avaliado pelo Ki-67 em osteossarcomas humanos
by: Larissa Cardoso Marinho, et al.
Published: (2005-12-01)

Glucose transporter 1 expression in bladder carcinoma and its association with human epidermal growth factor receptor-2 and Ki-67
by: Sheeja Sainulabdeen, et al.
Published: (2019-01-01)

Immunohistochemical expression of markers Ki-67, neun, synaptophysin, p53 and HER2 in medulloblastoma and its correlation with clinicopathological parameters Expressão imunoistoquímica dos marcadores Ki-67, neun, sinaptofisina, p53 e HER2 em meduloblastoma e sua correlação com os parâmetros clínico-patológicos
by: Rosalva Thereza Meurer, et al.
Published: (2008-06-01)

Relationship Between SUVmax and Ki-67 Expression in Breast Cancer
by: Meriç Emre Bostancı, et al.
Published: (2020-09-01)

Relationship Between Ultrasound Features and Ki-67 Labeling Index of Soft Tissue Sarcoma
by: Pingping Wang, et al.
Published: (2021-06-01)

HER2 Positive and HER2 Negative Classical Type Invasive Lobular Carcinomas: Comparison of Clinicopathologic Features
by: Lin He, et al.
Published: (2021-04-01)

Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es salaam, Tanzania
by: Amos Rodger Mwakigonja, et al.
Published: (2017-11-01)

Evaluation of Bcl 2 and Ki 67 expression in Chronic Lymphocytic Leukemia .
by: Subh S. AL- Mudallal, et al.
Published: (2013-01-01)

Immunohistochemicai study of Ki- 67 expression in unicystic Ameloblastoma and Dentigerous cyst
by: Eslami M., et al.
Published: (2004-06-01)

Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung
by: Rashi GARG, et al.
Published: (2019-01-01)

Expression and clinicopathological correlation of Ki-67 in gallbladder carcinoma
by: Amit Gupta, et al.
Published: (2021-01-01)

Expression of p53, Ki67, epidermal growth factor receptor, transforming growth-factorα, and p21 in primary and secondary hyperparathyroidism
by: Saime Paydas, et al.
Published: (2014-01-01)